
US-based Audax Medical develops orthopedic biomaterials and medical instruments for bone and tissue regeneration, specializing in orthobiologics.
Founded in Concord, United States, Audax Medical is a medical device company dedicated to developing advanced orthopedic biomaterials and medical instruments for the treatment of degenerative bone and musculoskeletal tissue. The company's core mission is to enhance patient outcomes through innovative orthobiologics that support tissue regeneration and long-term functionality. Audax Medical's flagship product, Arxis, is a biomaterial designed to provide mechanical support to injury sites while stimulating tissue regeneration. The company's market focus includes injectable therapies and pre-fabricated solutions for musculoskeletal disorders.
Audax Medical has garnered attention for its pioneering work in orthobiologics, attracting notable investors and industry experts. The company's achievements include the successful development and commercialization of Arxis, which has shown promising results in clinical applications. Through its innovative approach, Audax Medical has made a significant impact on the field of orthopedic medicine, offering new hope for patients suffering from degenerative bone and tissue conditions.

Novum Medical

Arsenal Medical
arsenalmedical.com

Bioventus

Bone Biologics

OsteoNovus
osteonovus.com

Adient Medical
adientmedical.com

Atreon Orthopedics
atreonortho.com

RevOrtho
revortho.com

Akros Medical

Axogen
axogeninc.com

Avitus Orthopaedics
avitusortho.com

Metric Medical Devices

AOI Medical

Xtant Medical Holdings
xtantmedical.com

MiMedx Group
mimedx.com
Companies similar to Audax Medical include Novum Medical, Arsenal Medical, Bioventus and Bone Biologics.
Audax Medical was founded in 2009.
Audax Medical's headquarters is located in Concord, MA, US.
Audax Medical's most recent funding round was for $135k (USD) in May 2010.
As of May 27, 2010, Audax Medical has raised a total of $687.5k (USD).
Audax Medical has 2 employees as of Feb 5, 2024.